... but back to reality with a lowered guidance. Bayer’s Q2 sales were up +3% (v: -2%; p: +4%; FX: +1%) to €12,193m and the gross profit margin moved from 57.5% to 58.0%. EBITDA was nearly unchanged (+1% to €2,983m) and net profit attributable to shareholders dropped 11% to €1,224m, burdened by higher minorities. Operating CF rose +17% to €2,313m, primarily due to lower changes in pension provisions and a lower NWC outflow (€-54m after €-224m). The latter&r
27 Jul 2017
Not a D-Day ...
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Not a D-Day ...
Bayer AG (BAYN:WBO) | 0 0 0.5% | Mkt Cap: 80,975m
- Published:
27 Jul 2017 -
Author:
Martin Schnee -
Pages:
4
... but back to reality with a lowered guidance. Bayer’s Q2 sales were up +3% (v: -2%; p: +4%; FX: +1%) to €12,193m and the gross profit margin moved from 57.5% to 58.0%. EBITDA was nearly unchanged (+1% to €2,983m) and net profit attributable to shareholders dropped 11% to €1,224m, burdened by higher minorities. Operating CF rose +17% to €2,313m, primarily due to lower changes in pension provisions and a lower NWC outflow (€-54m after €-224m). The latter&r